PAINWeek National Conference

Healio brings you the highlights from PAINWeek National Conference. Refer back to this page often for the latest news from PAINWeek, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

Machine learning tool may determine opioid use disorder risk

September 24, 2018
Using data found on health care claims, researchers developed a machine learning tool that resulted in a “high level of predictive…
Meeting News

Nucynta ER poses lower risk for abuse than other opioids

September 13, 2018
The risk for abuse was significantly lower among patients using Nucynta extended release than abuse-deterrent formulation opioids and non-abuse…
Meeting News

Overuse of triptans for migraine relief common

September 12, 2018
Approximately 16% of patients with migraine who were prescribed triptans overused the medication, according to data presented at PainWeek 2018…
Meeting News

Sumatriptan injection provides significant pain freedom from migraines

September 7, 2018
A low dose of sumatriptan provided significantly higher 2-hour pain freedom and 2-hour pain relief vs. placebo, according to phase 3 trial findings…
Meeting News

Fremanezumab may reduce frequency of migraine attack

September 6, 2018
Fremanezumab — a fully humanized monoclonal antibody targeting a calcitonin gene-related peptide that researchers said has already demonstrated…
Meeting News

Multimodal analgesia reduces opioid use for post-cesarean section pain

September 5, 2018
A multimodal analgesia approach decreased the amount of opioids prescribed at discharge, adequately controlled pain and reduced hospital length of…
Meeting News

Novel oxycodone abuse-deterrent formula effective for chronic pain

September 22, 2017
Oxycodone DETERx ER, an extended-release, abuse-deterrent drug, safely and effectively managed chronic pain in patients with poorly managed pain…
Meeting News

Two studies show promising results for NKTR-181

September 15, 2017
Patients receiving the opioid analgesic NKTR-181 had reduced back pain and exhibited low rates of opioid withdrawal, compared their counterparts who…
Meeting News

Lasmiditan provides faster migraine pain relief vs. placebo

September 13, 2017
Compared with placebo, lasmiditan reduced migraine pain and symptoms after 2 hours for most patients with at least moderate disability, according to…
Meeting News

New drug effective, well tolerated in patients with osteoarthritis knee pain

September 8, 2017
In patients with moderate to severe osteoarthritis knee pain, a single intra-articular injection of 1 mg of CNTX-4975 was well tolerated and…